New patent for Emd Serono drug MAVENCLAD

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MAVENCLAD
Annual Drug Patent Expirations for MAVENCLAD

Mavenclad is a drug marketed by Emd Serono Inc and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.

This drug has one hundred and fifteen patent family members in thirty-three countries.

The generic ingredient in MAVENCLAD is cladribine. One supplier is listed for this compound. Additional details are available on the cladribine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top